S1 Text.
Supplementary methods: determination of the vector type for localized transduction of the mouse SC.
The viral vectors used to determine the serotype for optimal transduction of the mouse SC, were produced by the Viral Vector Core of KU Leuven, as described previously by Van der Perren et al. [1] . Four rAAV vectors, expressing the enhanced green fluorescent protein (eGFP) gene under control of the general cytomegalovirus (CMV) promoter, were tested for transduction in the SC. The vectors all contained the inverted terminal repeats (ITRs) of AAV2, but were cross packaged in the capsids of AAV1, AAV7, AAV8, or AAV9, resulting in four different vector serotypes: rAAV2/1 (1.10E12 GC/ml), rAAV2/7 (1.90E12 GC/ml), rAAV2/8 (2.61E12 GC/ml), and rAAV2/9 (3.20E12 GC/ml). In order to examine possible retrograde transduction of the retina after viral vector injection into the SC, double IHC labeling for eGFP and Brn3a was performed on whole-mount retinas, following the Brn3a protocol described in the main text, with addition of the polyclonal primary antibody rabbit anti-eGFP (1:10,000, provided by Prof. V. Baekelandt [2] ) and the polyclonal secondary donkey Alexa Fluor-conjugated anti-rabbit IgG (Invitrogen, CA, USA).
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